Form 4 for DYN Dyne Therapeutics, Inc.
Accepted 2024-09-03 00:00:00 ET · period of report 2024-09-03 · accession 0000950170-24-103037 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-09-03 | 2024-09-03 | DYN | Kerr Douglas | Chief Medical Off | A - Grant | $0.00 | +47.5K | 47.5K | New | $0 |
| D | 2024-09-03 | 2024-09-03 | DYN | Kerr Douglas | Chief Medical Off | A - Grant | $0.00 | +150.3K | 150.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-03 | A | A | 47,500 | $0.00 | 47,500 | D | — | — | (F1) Consists of shares of Common Stock issuable under 47,500 restricted stock units ("RSU"). Each RSU represents the right to receive one share of Common Stock upon vesting. These RSUs are scheduled to vest in equal annual installments over four years with the first installment vesting on September 3, 2025. |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-09-03 | A | A | 150,300 | $0.00 | 150,300 | D | $31.94 · — to 2034-09-02 | 150,300 Common Stock | (F2) This option was granted on September 3, 2024. The shares underlying the option are scheduled to vest over four years, with 25% of the shares vesting on September 3, 2025, and the remainder vesting in equal quarterly installments thereafter, subject to continuous service. |